Johnson & Johnson Sells U.S. Rights to St. Joseph’s Asprin for Undisclosed Sum

WSJ -- Johnson & Johnson sold its St. Joseph’s aspirin brand to a closely held Baltimore company for an undisclosed sum, the companies said Thursday.

MORE ON THIS TOPIC